The recognition of PDCD1 as a shared hub gene in two separate datasets (GSE249956 and GSE98206), along with its potential for drug targeting, indicates that immune checkpoint–mediated immune evasion might play a role in ibrutinib resistance in chronic lymphocytic leukemia (CLL). The gene discussed is PDCD1; the disease is B-cell chronic lymphocytic leukemia.